Background: Survival studies in differentiated thyroid carcinoma (DTC) may be biased
because they have been performed in heterogeneous populations. In addition, specific …

Objective: Differentiated thyroid carcinoma (DTC) generally has a good prognosis. As yet,
however, it is unclear whether life expectancy is reduced in these patients and, if so, to what …

Background The study evaluates clinical presentation and outcome of differentiated thyroid
cancer (DTC) on a large series of patients homogeneously managed. Patients and methods …

BACKGROUND Different scoring systems currently are being used to stratify patients with
differentiated thyroid carcinoma (DTC) into risk groups. DTC is usually subdivided into …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all
thyroid cancers. Our objective is to report outcomes in a large series of patients with PDTC …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

In differentiated thyroid carcinoma 10-year survival rates amount to 80–95%. Because age
at diagnosis varies widely, these survival rates strongly depend on age at presentation. The …

Background Risk‐group stratification based on prognostic factors is well established in
differentiated carcinoma of the thyroid gland. Patients in the low‐risk group have an …

Differentiated thyroid carcinomas (DTC)(papillary, follicular and follicular type of papillary)
have a favourable prognosis, but a proportion of patients develop recurrences and …